Cargando…
Examining the relationship between metformin dose and cancer survival: A SEER-Medicare analysis
Cancer is a major health problem in the U.S and type 2 diabetes mellitus (T2DM) is known to increase the risk for the development of many cancers. Metformin, a first-line therapy for treating T2DM, is increasingly being used for its anticancer effects; however, the literature is limited on the effec...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581409/ https://www.ncbi.nlm.nih.gov/pubmed/36260549 http://dx.doi.org/10.1371/journal.pone.0275681 |